Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Stefan J. Hutten"'
Autor:
Françoise Derouane, Manon Desgres, Camilla Moroni, Jérôme Ambroise, Martine Berlière, Mieke R. Van Bockstal, Christine Galant, Cédric van Marcke, Marianela Vara-Messler, Stefan J. Hutten, Jos Jonkers, Larissa Mourao, Colinda L. G. J. Scheele, Francois P. Duhoux, Cyril Corbet
Publikováno v:
Breast Cancer Research, Vol 26, Iss 1, Pp 1-19 (2024)
Abstract Background Neoadjuvant chemotherapy (NAC) is the standard of care for patients with early-stage triple negative breast cancers (TNBC). However, more than half of TNBC patients do not achieve a pathological complete response (pCR) after NAC,
Externí odkaz:
https://doaj.org/article/cbcb7ddcc69b4cbbb96f42be1600415c
Publikováno v:
STAR Protocols, Vol 4, Iss 3, Pp 102526- (2023)
Summary: Mouse intraductal modeling enables efficient in vivo propagation of pre-invasive breast cancer lesions and provides a suitable micro-environment for creating patient-derived tumor xenograft models of estrogen-receptor-positive breast cancer.
Externí odkaz:
https://doaj.org/article/3f07c5b166cd46f6913e631d540bdc5f
Autor:
Stefan J. Hutten, Jos Jonkers
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 8, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/696e7715efb64a328fc3634ee795a9ec
Autor:
Stefan J Hutten, Danny S Hamers, Marije Aan den Toorn, Wilma van Esse, Antsje Nolles, Christoph A Bücherl, Sacco C de Vries, Johannes Hohlbein, Jan Willem Borst
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169905 (2017)
Brassinosteroids (BRs) are plant hormones that are perceived at the plasma membrane (PM) by the ligand binding receptor BRASSINOSTEROID-INSENSITIVE1 (BRI1) and the co-receptor SOMATIC EMBRYOGENESIS RECEPTOR LIKE KINASE 3/BRI1 ASSOCIATED KINASE 1 (SER
Externí odkaz:
https://doaj.org/article/be11549e51c24d4ab6673eee04950e2c
Autor:
Stefan J. Hutten, Roebi de Bruijn, Catrin Lutz, Madelon Badoux, Timo Eijkman, Xue Chao, Marta Ciwinska, Andrea Herencia-Ropero, Petra Kristel, Lennart Mulder, Joyce Sanders, Mathilde Almekinders, Alba Llop-Gueverra, Helen R. Davies, Fariba Behbod, Serena Nik-Zainal, Violeta Serra, Jacco van Rheenen, Esther H. Lips, Lodewyk F.A. Wessels, Jelle Wesseling, Colinda Scheele, Jos Jonkers
Publikováno v:
Cancer Prevention Research. 15:PR006-PR006
Ductal Carcinoma in Situ (DCIS) is a non-invasive non-obligate precursor of invasive breast cancer (IBC). DCIS is usually treated by surgery combined with radiotherapy, which can have a large impact on the life of patients. However, many of these DCI
Autor:
Jelle Wesseling, Colinda L.G.J. Scheele, Timo Eijkman, Jos Jonkers, Madelon Badoux, Stefano Annunziatio, Stefan J. Hutten, Catrin Lutz
Publikováno v:
Cancer Research. 80:B37-B37
Ductal carcinoma in situ (DCIS) is a starting lesion in the milk duct of the breast, which accounts for 25% of all “breast cancers” detected. DCIS is usually treated by surgery combined with radiotherapy, which can have a large impact on the life
Autor:
Catrin Lutz, J. Van Rheenen, Jos Jonkers, Stefano Annunziato, Stefan J. Hutten, Colinda L.G.J. Scheele, Jelle Wesseling
Publikováno v:
ESMO Open. 3:A150-A151
Introduction Ductal Carcinoma in Situ (DCIS) is a starting lesion in the milk duct of the breast, which accounts for 25% of all ‘breast cancers’ detected since the introduction of breast screening. DCIS is usually treated by surgery combined with
Autor:
Christoph A. Bücherl, Sacco C. de Vries, Antsje Nolles, Jan Willem Borst, Marije aan den Toorn, Danny S. Hamers, Wilma G. van Esse, Johannes Hohlbein, Stefan J. Hutten
Publikováno v:
PLoS ONE
PLoS ONE, 12(1)
PLoS ONE, Vol 12, Iss 1, p e0169905 (2017)
PLoS ONE 12 (2017) 1
PLoS ONE, 12(1)
PLoS ONE, Vol 12, Iss 1, p e0169905 (2017)
PLoS ONE 12 (2017) 1
Brassinosteroids (BRs) are plant hormones that are perceived at the plasma membrane (PM) by the ligand binding receptor BRASSINOSTEROID-INSENSITIVE1 (BRI1) and the co-receptor SOMATIC EMBRYOGENESIS RECEPTOR LIKE KINASE 3/BRI1 ASSOCIATED KINASE 1 (SER
Autor:
Catrin Lutz, Stefan J. Hutten, Ellen Tanger, Jos Jonkers, Stefano Annunziato, Jelle Wesseling
Publikováno v:
Cancer Research. 78:5115-5115
Ductal Carcinoma in Situ (DCIS) is a starting lesion in the milk duct of the breast, which accounts for 25% of all ‘breast cancers' detected since the introduction of breast screening. DCIS is usually treated by surgery combined with radiotherapy,